GHTC signed a Defense Health Research Consortium (DHRC) letter to Congress urging enactment of the fiscal year 2022 (FY22) Defense Appropriations Act to ensure that the Defense Health Research Programs, including the Congressionally Directed Medical Research Programs, are fully funded in FY22.PDF
GHTC’s director Jamie Bay Nishi was invited by the White House to deliver video remarks for the Global COVID-19 Summit held on September 22, 2021.Learn more
GHTC Director Jamie Bay Nishi was interviewed as part of a Mediaplanet campaign on neglected tropical diseases (NTDs) that was featured in the Guardian.View
The Infectious Diseases Society of America (ISDA) is an organization of physicians, scientists, and other health care professionals dedicated to promoting health through excellence in infectious diseases research, education, prevention, and patient care. The society, which has nearly 10,000 members, was founded in 1963 and is based in Arlington, VA.VIEW
Why we're needed
Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity within reach for all people.Learn More
GHTC endorsed two letters from the Global Health Council's Tuberculosis (TB) Roundtable to the White House Office of Management and Budget urging support for domestic and global TB programs in the fiscal year 2023 budget.Learn more
GHTC Multilateral Policy and Advocacy Officer Philip Kenol was selected as a finalist for Washington Global Health Alliance's (WGHA) Rising Star Award, which recognizes an individual age 40 or under who is making an exceptional impact in a global health organization or initiative.Learn more
ANOTHER TRIUMPH OF SCIENCE, BUT DEFEAT FOR ACCESS? Ensuring innovation and equitable access for COVID-19 treatments and other pandemics
Drugs for Neglected Diseases initiative
Triangle Global Health Consortium
mRNA vaccines exemplify how basic discovery research coupled with targeted translational investments remain the engine of transformative innovations that save uncountable lives and immeasurably improve their quality. GHTC and Sabin share insights from key science and policy leaders involved in Sabin’s Influenzer Initiative on the promising potential of mRNA technology.
Research Roundup: G7 nations pledge 870 million doses, vaccines appear effective against variants, and Wolbachia trial reduces dengue infections
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
How the G7 can help end the current pandemic—and lay the foundation for a new health security architecture
This weekend, leaders from the G7 will come together in Cornwall, England, seeking to revive multilateralism and highlight that this forum can still play a significant role in shaping and responding to major world events. Here's a look at how G7 leaders can tackle the COVID-19 pandemic, build long-term infrastructure to prevent future health outbreaks, and seize the moment to reimagine the future of global health security.